Ernest Mario School of Pharmacy

What Ernest Mario School of Pharmacy does

Ernest Mario School of Pharmacy is a school of pharmacy within Rutgers, The State University of New Jersey, a public research university. The school offers a six-year Doctor of Pharmacy (PharmD) program with direct entry from high school, alongside graduate (MS and PhD) programs in Medicinal Chemistry, Pharmaceutical Science, and Toxicology.

The school's research enterprise is anchored by the CounterACT Research Center of Excellence, funded by a $19.4 million grant from the National Institutes of Health (NIH), and a Joint Graduate Program in Toxicology (JGPT) administered through the Environmental and Occupational Health Sciences Institute (EOHSI). Additional federally funded research includes a National Institute of Environmental Health Sciences (NIEHS) T32 Training Grant in Environmental Toxicology that has been continuously active for over 30 years. Over a 10-year window, departmental research funding has totaled more than $30 million, with active NIH programs at nearly $7 million. Other funding sources include the National Science Foundation (NSF), the Department of Defense (DOD), and the American Lung Association. A $50 million Rutgers Health Pilot Award supports Chlamydia research at the school.

The school's revenue model is a hybrid of public higher-education funding mechanisms — including tuition, state appropriations, and competitive research grants — rather than commercial product or service revenue. Because it operates as a non-commercial academic unit within a state university, traditional commercial revenue metrics do not apply; financial scale is better measured by research expenditures, enrollment, and grant funding rather than ARR or unit pricing.

Name

Ernest Mario School of Pharmacy

Legal name

Ernest Mario School of Pharmacy

Website

https://pharmacy.rutgers.edu

Company type

Private

Founded year

1899

Operating status

Operating

Short description

Ernest Mario School of Pharmacy is the pharmacy school of Rutgers, The State University of New Jersey, offering a six-year PharmD program and graduate research degrees in pharmaceutical sciences, medicinal chemistry, and toxicology.

Ownership category

akta.pro rank

Product category

Higher Education - Pharmacy Education

NAICS

Colleges, Universities, and Professional Schools (6113)

SIC

Services-Educational Services (8200)

akta.pro industry

PRIMARYEDAHAGAE

Schools of Pharmacy

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

SECONDARYEDAAALAC

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy)

Education/Adult & Continuing Education/Professional Licensure & Continuing Professional Education (CE/CPE)

Keywords

• Pharmacy education
• Pharmaceutical sciences
• Medicinal chemistry
• Toxicology research
• Graduate research programs

Headquarters

HQ city

Piscataway

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Tuition and Fees: Revenue from Doctor of Pharmacy (PharmD) program, graduate programs (MS/PhD), and continuing education programs for practicing pharmacists
2. Research Grants and Funding: NIH, NIEHS, NSF, DOD, and other federal agency grants supporting faculty research; CounterACT center funded with $19.4 million NIH grant; nearly $7 million in active NIH research programs
3. Industry Partnerships: Postdoctoral industry fellowships through Rutgers Institute for Pharmaceutical Industry Fellowships; pharmaceutical company collaborations for research and training
4. Donations and Endowments: Private donations supporting research and training funds; named scholarships and endowed chairs

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Core offering

Ernest Mario School of Pharmacy is an educational institution offering a portfolio of pharmacy and pharmaceutical science degree programs. The core offerings include a six-year Doctor of Pharmacy (PharmD) program with direct entry from high school, multiple graduate programs (MS and PhD) in Medicinal Chemistry, Pharmaceutical Science, and Toxicology, and a Health Outcomes, Policy and Economics (HOPE) MS program. The school also conducts research in drug discovery, drug delivery, anticancer prodrugs, antiviral agents, and toxicology, supported by NIH grants and industry partnerships.

Product overview

Ernest Mario School of Pharmacy is an educational institution offering a portfolio of pharmacy and pharmaceutical science degree programs. The core offerings include a six-year Doctor of Pharmacy (PharmD) program (one of the few 0-6 direct-entry programs in the country), multiple graduate programs (MS and PhD) in Medicinal Chemistry, Pharmaceutical Science, and Toxicology, and a Health Outcomes, Policy and Economics (HOPE) MS program. Supplementary programs include an Honors Research Program for high-achieving PharmD students, dual PharmD/PhD degree pathways, and simulation-based education through the SCARLET initiative. The school operates with research focus areas including antiviral drug discovery, drug delivery, anticancer prodrugs, and toxicology, located in central New Jersey.

Differentiator

Problem solved

Functional benefit

Products and services

• Doctor of Pharmacy (PharmD) Program
• Graduate Program in Pharmaceutical Science (MS and PhD)

Quantifiable outcome

• 94.8% first-attempt NAPLEX pass rate
• +4 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Eleven partnerships are on record, tiered core and major.

• Rutgers School of Public HealthcoreStrategic or Co-development PartnerJoint academic partnership offering MS in Health Outcomes, Policy, and Economics; combined programs expand access to specialized training in health economics, outcomes research, and policy
• Environmental and Occupational Health Sciences Institute (EOHSI)coreStrategic or Co-development PartnerJGPT administratively housed at EOHSI; draws on mentors from over 17 departments for multidisciplinary training in toxicology
• CounterACT Research Center of Excellence Partners (Lehigh University, New York Medical College)coreStrategic or Co-development PartnerFederally funded initiative to develop medical countermeasures against high-priority chemical weapons; collaboration of Rutgers, Lehigh University, and NYMC with $19.4M NIH grant
• Robert Wood Johnson Medical SchoolmajorStrategic or Co-development PartnerMultidisciplinary collaborations with investigators; joint MD/PhD program; shared faculty and research programs
• Rutgers Institute for Pharmaceutical Industry FellowshipscoreStrategic or Co-development PartnerLargest postdoctoral industry fellowship training program in the nation; clinical faculty collaborate with fellows on scholarly activities
• Healthcare Systems and Hospitals (1,250+ clinical sites)coreChannel Partner/ Reseller/ DistributorClinical rotation sites for pharmacy students providing experiential education across diverse healthcare settings throughout New Jersey
• Daiichi SankyomajorStrategic or Co-development PartnerPostdoctoral industry fellowship with oncology medical affairs team; Stacey Zhang completing fellowship with company's oncology medical affairs team
• Emory University Rollins School of Public HealthmajorStrategic or Co-development PartnerCollaborative research with Dr. Shuo Xiao on wildfire smoke impacts on fertility and reproductive health, funded by NIEHS
• Pharmaceutical Industry PartnersmajorStrategic or Co-development PartnerLocal pharmaceutical companies provide financial support for graduate students through fellowships; Adjunct faculty from Merck, BMS, Sanofi, Teva, and other companies
• Rutgers Health Placenta Research GroupmajorStrategic or Co-development PartnerMulti-institutional study on role of placenta in fetal development led by Dr. Lauren Aleksunes; investigates chemical safety during pregnancy
• Rutgers School of EngineeringmajorStrategic or Co-development PartnerCollaboration with Philip Demokritou (Henry Rutgers Chair, nanoscience and environmental bioengineering) on wildfire health impacts research

Scale indicators14 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• University of Pittsburgh School of Pharmacy: Research-intensive pharmacy school offering PharmD, MS/PhD programs in pharmaceutical sciences and clinical pharmacy. Similar to EMSOP in NIH funding standing, graduate research output, and interprofessional health-sciences positioning.
• University of Washington School of Pharmacy: Top-ranked UW pharmacy school offering PharmD and graduate research programs in drug discovery, pharmacokinetics, and pharmacoanalytics. Comparable to EMSOP for ranking tier, federal research funding scale, and breadth of dual-degree paths.
• University of Michigan College of Pharmacy: Top-ranked research pharmacy school with PharmD and PhD programs in pharmaceutical sciences, medicinal chemistry, and clinical pharmacy. Comparable to EMSOP in offering interprofessional education, joint degrees, and substantial NIH-funded research centers.
• University of Illinois Chicago College of Pharmacy: Large research pharmacy school with PharmD and PhD programs; nationally ranked and housed within a public research university. Direct peer to EMSOP given comparable scale, public-university structure, and dual PharmD/PhD offerings.
• University of North Carolina Eshelman School of Pharmacy: The nation's #1-ranked pharmacy school offering PharmD and graduate research programs in medicinal chemistry, pharmacoengineering, and pharmacotherapy. Direct peer to EMSOP in the Top-25 pharmacy school tier, with comparable NIH funding scale and graduate program breadth.
• Ohio State University College of Pharmacy: Top-10 ranked pharmacy school within a large public research university; offers PharmD and graduate programs in pharmaceutical sciences and medicinal chemistry. Comparable to EMSOP on public-R1 settings, NIH research standing, and breadth of graduate specialties.
• Purdue University College of Pharmacy: Top-10 ranked pharmacy school known for industrial and physical pharmacy research alongside PharmD training. Comparable to EMSOP via NIH-funded research centers, dual PharmD/PhD pipelines, and industry-adjacent location enabling fellowship placements.
• University of California San Francisco (UCSF) School of Pharmacy: Top-ranked U.S. pharmacy school with deep research programs in pharmaceutical sciences and pharmacogenomics, frequently #1 or #2 ranked. Direct peer along the dimensions of NIH funding share, graduate research scale, and PharmD program quality that define EMSOP's competitive set.
• University of Maryland School of Pharmacy: Research-intensive pharmacy school with strong pharmaceutical sciences and pharmacometrics research programs; ranked in Top 20 nationally. Direct peer along the same structural lines as EMSOP—public university, NIH center-level research funding, multiple graduate programs.
• University of Minnesota College of Pharmacy: Research-intensive pharmacy school delivering PharmD and PhD/MS programs in medicinal chemistry, pharmacotherapy, and experimental & clinical pharmacology. Comparable in scale, NIH funding tier, and offering of experiential education networks.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ernest Mario School of Pharmacy